Indeed, pre-treatment of cells with soluble EPHA2 inhibited KSHV infection up to 90% in all cell lines observed, and a similar reduction of infection was seen when pre-treating cells with the soluble EPHA2 ligand, ephrinA4 [51]. Here, EPHA2 is linked to infection.